90 related articles for article (PubMed ID: 22728161)
1. Squalenoyl prodrug of paclitaxel: synthesis and evaluation of its incorporation in phospholipid bilayers.
Sarpietro MG; Ottimo S; Paolino D; Ferrero A; Dosio F; Castelli F
Int J Pharm; 2012 Oct; 436(1-2):135-40. PubMed ID: 22728161
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers.
Sarpietro MG; Ottimo S; Giuffrida MC; Rocco F; Ceruti M; Castelli F
Int J Pharm; 2011 Mar; 406(1-2):69-77. PubMed ID: 21219999
[TBL] [Abstract][Full Text] [Related]
3. Conjugation of squalene to acyclovir improves the affinity for biomembrane models.
Sarpietro MG; Micieli D; Rocco F; Ceruti M; Castelli F
Int J Pharm; 2009 Dec; 382(1-2):73-9. PubMed ID: 19686827
[TBL] [Abstract][Full Text] [Related]
4. Lipophilic prodrug of paclitaxel: interaction with a dimyristoylphosphatidylcholine monolayer.
Giuffrida MC; Dosio F; Castelli F; Sarpietro MG
Int J Pharm; 2014 Nov; 475(1-2):624-31. PubMed ID: 25234865
[TBL] [Abstract][Full Text] [Related]
5. DSC and EPR investigations on effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within lipid bilayer membrane.
Zhao L; Feng SS; Kocherginsky N; Kostetski I
Int J Pharm; 2007 Jun; 338(1-2):258-66. PubMed ID: 17337138
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of gemcitabine affinity for biomembranes by conjugation with squalene: differential scanning calorimetry and Langmuir-Blodgett studies using biomembrane models.
Castelli F; Sarpietro MG; Micieli D; Stella B; Rocco F; Cattel L
J Colloid Interface Sci; 2007 Dec; 316(1):43-52. PubMed ID: 17765257
[TBL] [Abstract][Full Text] [Related]
7. Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface.
Sarpietro MG; Rocco F; Micieli D; Ottimo S; Ceruti M; Castelli F
Int J Pharm; 2010 Aug; 395(1-2):167-73. PubMed ID: 20635474
[TBL] [Abstract][Full Text] [Related]
8. Improving the antitumor activity of squalenoyl-paclitaxel conjugate nanoassemblies by manipulating the linker between paclitaxel and squalene.
Caron J; Maksimenko A; Wack S; Lepeltier E; Bourgaux C; Morvan E; Leblanc K; Couvreur P; Desmaële D
Adv Healthc Mater; 2013 Jan; 2(1):172-85. PubMed ID: 23213041
[TBL] [Abstract][Full Text] [Related]
9. Effects of lipid chain unsaturation and headgroup type on molecular interactions between paclitaxel and phospholipid within model biomembrane.
Zhao L; Feng SS
J Colloid Interface Sci; 2005 May; 285(1):326-35. PubMed ID: 15797430
[TBL] [Abstract][Full Text] [Related]
10. Interaction of the anticancer agent Taxol (paclitaxel) with phospholipid bilayers.
Bernsdorff C; Reszka R; Winter R
J Biomed Mater Res; 1999 Aug; 46(2):141-9. PubMed ID: 10379991
[TBL] [Abstract][Full Text] [Related]
11. Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembranes.
Zhao L; Feng SS
J Colloid Interface Sci; 2004 Jun; 274(1):55-68. PubMed ID: 15120278
[TBL] [Abstract][Full Text] [Related]
12. Characterization of lipophilic gemcitabine prodrug-liposomal membrane interaction by differential scanning calorimetry.
Castelli F; Sarpietro MG; Ceruti M; Rocco F; Cattel L
Mol Pharm; 2006; 3(6):737-44. PubMed ID: 17140261
[TBL] [Abstract][Full Text] [Related]
13. Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation.
Dosio F; Reddy LH; Ferrero A; Stella B; Cattel L; Couvreur P
Bioconjug Chem; 2010 Jul; 21(7):1349-61. PubMed ID: 20597546
[TBL] [Abstract][Full Text] [Related]
14. Amphiphilic naproxen prodrugs: differential scanning calorimetry study on their interaction with phospholipid bilayers.
Giuffrida MC; Pignatello R; Castelli F; Sarpietro MG
J Pharm Pharmacol; 2017 Sep; 69(9):1091-1098. PubMed ID: 28620994
[TBL] [Abstract][Full Text] [Related]
15. Biomimesis of linolenic acid transport through model lipidic membranes by differential scanning calorimetry.
Castelli F; Caruso S; Uccella N
J Agric Food Chem; 2003 Feb; 51(4):851-5. PubMed ID: 12568537
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery by an enzyme-mediated cyclization of a lipid prodrug with unique bilayer-formation properties.
Linderoth L; Peters GH; Madsen R; Andresen TL
Angew Chem Int Ed Engl; 2009; 48(10):1823-6. PubMed ID: 19173369
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study.
Elsadek B; Graeser R; Esser N; Schäfer-Obodozie C; Abu Ajaj K; Unger C; Warnecke A; Saleem T; El-Melegy N; Madkor H; Kratz F
Eur J Cancer; 2010 Dec; 46(18):3434-44. PubMed ID: 20933385
[TBL] [Abstract][Full Text] [Related]
18. β-Phase formation of poly(9,9-dioctylfluorene) induced by liposome phospholipid bilayers.
Tapia MJ; Monteserín M; Burrows HD; de Melo JS; Pina J; Castro RA; García S; Estelrich J
J Phys Chem B; 2011 May; 115(19):5794-800. PubMed ID: 21520954
[TBL] [Abstract][Full Text] [Related]
19. Location of [60]fullerene incorporation in lipid membranes.
Ikeda A; Kiguchi K; Shigematsu T; Nobusawa K; Kikuchi J; Akiyama M
Chem Commun (Camb); 2011 Nov; 47(44):12095-7. PubMed ID: 21959648
[TBL] [Abstract][Full Text] [Related]
20. Development of first photoresponsive prodrug of paclitaxel.
Skwarczynski M; Noguchi M; Hirota S; Sohma Y; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2006 Sep; 16(17):4492-6. PubMed ID: 16806915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
